Reduction of hospital mortality in patients with ST segment elevation myocardial infarction receiving IIb/IIIa antagonists: results of the ACOS-registry

被引：0
作者：
Gitt, AK
Schiele, R
Wienbergen, H
Heer, T
Meisenzahl, C
Gottwik, MG
Bestehorn, K
Senges, J
机构：
[1] Herzzentrum Ludwigshafen, Ludwigshafen, Germany
[2] Klinikum Nurnberg Sud, Nurnberg, Germany
[3] MSD, Haar, Germany
来源：
EUROPEAN HEART JOURNAL | 2002年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [41] Impact of HDL cholesterol on hospital and 1-year-mortality of patients with acute myocardial infarction: results of the ACOS registry
    Towae, F.
    Wienbergen, H.
    Heer, T.
    Schiele, R.
    Gottwik, M. G.
    Senges, J.
    Gitt, A. K.
    EUROPEAN HEART JOURNAL, 2005, 26 : 47 - 47
  • [42] Management and in-hospital mortality of patients with non-ST-segment elevation vs. ST-segment elevation myocardial infarction in Kosovo
    Batalli, A.
    Poniku, A.
    Haliti, E.
    Shita, D.
    Ferati, A.
    Leka, R.
    Elezi, S.
    Shatri, F.
    Selmani, H.
    Bytyci, I.
    Henein, M. Y.
    Bajraktari, G. Gani
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 332 - 333
  • [43] Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
    Zwart, Bastiaan
    Yazdani, Momina
    Ow, Kok Weng
    Richardson, James D.
    Iqbal, Javaid
    Gunn, Julian P.
    Storey, Robert F.
    PLATELETS, 2020, 31 (02) : 174 - 178
  • [44] Combination therapy of glycoprotein IIb/IIIa inhibitors and a thienopyridine is associated with reduced hospital mortality in patients with non-ST elevation myocardial infarction managed invasively but not conservatively: Lessons from the National Registry of Myocardial Infarction 4
    Bromberg-Marin, G
    Parsons, LS
    Canto, JG
    Rogers, WJ
    CIRCULATION, 2004, 110 (17) : 540 - 540
  • [45] Early glycoprotein IIb/IIIa inhibitors in patients with non-ST-segment elevation myocardial infarction - Are we ready to open the floodgates?
    Stone, PH
    Yeghiazarians, Y
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (01) : 54 - 56
  • [46] PROGNOSTIC IMPACT OF THE UPSTREAM USE OF GP IIB/IIIA INHIBITORS IN SELECTED PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
    Malagoli, A.
    Magnavacchi, P.
    Tondi, S.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0G) : G30 - G30
  • [47] Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: Appropriate interpretation of the guidelines
    Antman, EM
    AMERICAN HEART JOURNAL, 2003, 146 (04)
  • [48] Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4)
    Bromberg-Marin, Guilherme
    Marin-Neto, Jose A.
    Parsons, Lori S.
    Canto, John G.
    Rogers, William J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (09) : 1125 - 1131
  • [49] Frequency and in-Hospital Mortality of Right Ventricular Infarction in Patients of Inferior ST-Segment Elevation Myocardial Infarction
    Akram, Muhammad
    Ali, Syed Nauman
    Zareef, Asif
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2015, 9 (04): : 1162 - 1165
  • [50] Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: Results of the German Prehospital Myocardial Infarction Registry (PREMIR)
    Zeymer, Uwe
    Arntz, Hans-Richard
    Dirks, Burkhardt
    Ellinger, Klaus
    Genzwuerker, Harald
    Nibbe, Lutz
    Tebbe, Ulrich
    Senges, Jochen
    Schneider, Steffen
    RESUSCITATION, 2009, 80 (04) : 402 - 406
12345